Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiwei Mou

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|July 26, 2011
Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1Yan Yang, Ying Liu, Xiaohong Yao, et al.
Hepatology (Baltimore, Md.)|June 13, 2019
Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic GenesSuet-Yan Kwan, Ankur Sheel, Chun-Qing Song, et al.
Genome Biology|May 29, 2015
A versatile reporter system for CRISPR-mediated chromosomal rearrangementsYingxiang Li, Angela I Park, Haiwei Mou, et al.
The Journal of Pathology|January 15, 2023
CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancerHaiwei Mou, Onur Eskiocak, Kadir A Özler, et al.
Hepatology (Baltimore, Md.)|May 27, 2020
YAP1 Withdrawal in Hepatoblastoma Drives Therapeutic Differentiation of Tumor Cells to Functional Hepatocyte-Like CellsJordan L Smith, Tomás C Rodríguez, Haiwei Mou, et al.
Gastroenterology|December 14, 2016
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in MiceChun-Qing Song, Yingxiang Li, Haiwei Mou, et al.
Nature Biotechnology|August 14, 2018
Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in miceDan Wang, Jia Li, Chun-Qing Song, et al.
Genome Biology|June 16, 2017
CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletionHaiwei Mou, Jordan L Smith, Lingtao Peng, et al.
Ebiomedicine|May 25, 2023
Patient-derived melanoma organoid models facilitate the assessment of immunotherapiesLingling Ou, Shujing Liu, Huaishan Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicityHuaishan Wang, Shujing Liu, Prithvi Sinha, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|July 26, 2011
Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1Yan Yang, Ying Liu, Xiaohong Yao, et al.
Hepatology (Baltimore, Md.)|June 13, 2019
Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic GenesSuet-Yan Kwan, Ankur Sheel, Chun-Qing Song, et al.
Genome Biology|May 29, 2015
A versatile reporter system for CRISPR-mediated chromosomal rearrangementsYingxiang Li, Angela I Park, Haiwei Mou, et al.
The Journal of Pathology|January 15, 2023
CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancerHaiwei Mou, Onur Eskiocak, Kadir A Özler, et al.
Hepatology (Baltimore, Md.)|May 27, 2020
YAP1 Withdrawal in Hepatoblastoma Drives Therapeutic Differentiation of Tumor Cells to Functional Hepatocyte-Like CellsJordan L Smith, Tomás C Rodríguez, Haiwei Mou, et al.
Gastroenterology|December 14, 2016
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in MiceChun-Qing Song, Yingxiang Li, Haiwei Mou, et al.
Nature Biotechnology|August 14, 2018
Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in miceDan Wang, Jia Li, Chun-Qing Song, et al.
Genome Biology|June 16, 2017
CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletionHaiwei Mou, Jordan L Smith, Lingtao Peng, et al.
Ebiomedicine|May 25, 2023
Patient-derived melanoma organoid models facilitate the assessment of immunotherapiesLingling Ou, Shujing Liu, Huaishan Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicityHuaishan Wang, Shujing Liu, Prithvi Sinha, et al.
Pageof 4